198 related articles for article (PubMed ID: 38077322)
21. The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas.
Zheng H; Zhao Y; Zhou H; Tang Y; Xie Z
Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759912
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment.
Cao PW; Liu L; Li ZH; Cao F; Liu FB
Front Genet; 2022; 13():853471. PubMed ID: 35547245
[TBL] [Abstract][Full Text] [Related]
23. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
[TBL] [Abstract][Full Text] [Related]
24. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
Zhai Y; Shen H; Wei H
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
[TBL] [Abstract][Full Text] [Related]
25. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
[TBL] [Abstract][Full Text] [Related]
26. The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients.
Yang LR; Lin ZY; Hao QG; Li TT; Zhu Y; Teng ZW; Zhang J
Cancer Cell Int; 2022 Jan; 22(1):10. PubMed ID: 34996458
[TBL] [Abstract][Full Text] [Related]
27. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
28. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
29. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer.
Li W; Wang X; Li C; Chen T; Zhou X; Li Z; Yang Q
Hum Cell; 2023 Jan; 36(1):393-408. PubMed ID: 36403174
[TBL] [Abstract][Full Text] [Related]
31. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L
BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
[No Abstract] [Full Text] [Related]
33. A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia.
Wu F; Xu G; Li G; Yin Z; Shen H; Ye K; Zhu Y; Zhang Q; Ou R; Liu S
Front Mol Biosci; 2023; 10():1281141. PubMed ID: 38161382
[No Abstract] [Full Text] [Related]
34. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102
[TBL] [Abstract][Full Text] [Related]
35. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
[TBL] [Abstract][Full Text] [Related]
36. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
Zhu Y; He J; Li Z; Yang W
BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
[TBL] [Abstract][Full Text] [Related]
37. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract][Full Text] [Related]
38. Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia.
Dao FT; Wang J; Yang L; Qin YZ
Sci Rep; 2021 Mar; 11(1):4856. PubMed ID: 33649342
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH
Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388
[TBL] [Abstract][Full Text] [Related]
40. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
